PHARMA NORD ApS: Financial statements 2016
CVR: 67303016
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PHARMA NORD ApS (CVR 67303016) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 337,277,000 and a net result of DKK 62,012,000 compared with DKK 55,784,198 the year before. That is a decrease of 19.2% compared with the year before. The profit margin was 18.4%. Equity in the 2016 report amounted to DKK 141,996,000. The solvency ratio was 44.5%. The company had 315 employees in the financial year.
- Revenue
- DKK 337,277,000
- Gross Profit
- DKK 149,402,000
- Profit/Loss
- DKK 62,012,000
- Equity
- DKK 141,996,000
- Total Assets
- DKK 319,064,000
- Employees
- 315
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 337.3 mio. | 149.4 mio. | 62 mio. | 142 mio. | 315 |
| 2015 | 417.5 mio. | 198.7 mio. | 55.8 mio. | - | 307 |
| 2014 | 317.1 mio. | 121.5 mio. | 30.2 mio. | 29.8 mio. | 285 |
| 2013 | 317.4 mio. | 98.7 mio. | 11.2 mio. | -215 t. | 275 |
Official annual report
Find more companies like PHARMA NORD ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PHARMA NORD ApS has published its annual report for 2015. Revenue came to DKK 417,476,102, and the net result was DKK 55,784,198.
About PHARMA NORD ApS
PHARMA NORD ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 1981. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO I ApS and PharmCo III ApS. The company has 199 employees (2018). In 2025, the company reported revenue of DKK 518,005,000 and a net result of DKK 26,711,000 compared with DKK 32,254,000 the year before. Equity in the 2025 report amounted to DKK 181,417,000.